10/16/2025
š” Ever wonder if you really need to stay on endocrine therapy for 10 years?
The Breast Cancer Index (BCI) test can help answer that.
This genomic test analyzes your tumor biology to determine two critical things:
1ļøā£ Your risk of late distant recurrence (years 5ā10)
2ļøā£ Whether continuing endocrine therapy is likely to benefit you.
BCI is now included in the NCCN Guidelines for HR+ early-stage breast cancer and helps patients and clinicians make personalized, evidence-based treatment decisions.
Swipe to learn what the test measures, how itās done, and why itās changing how we manage survivorship care.
At BePowerfuel, we help breast cancer survivors navigate hormone management, survivorship, and sexual health with clarity and confidence.
š¬ Have questions about your treatment or BCI testing? Send us a message or visit bepowerfuel.com to schedule a consultation.